Polymeric nanocarriers for the treatment of systemic iron overload

Autor: Jasmine L. Hamilton, Jayachandran N. Kizhakkedathu

Publikováno v: Molecular and cellular therapies

Desferrioxamine (DFO), deferiprone (L1) and desferasirox (ICL-670) are clinically approved iron chelators used to treat secondary iron overload. Although iron chelators have been utilized since the 1960s and there has been much improvement in availab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c3d42c0df902201c88bc03dfeaa72f7
https://doi.org/10.1186/s40591-015-0039-1

Polymeric nanocarriers for the treatment of systemic iron overload.

Autor: Hamilton JL; The Centre for Blood Research, Department of Pathology and Laboratory Medicine, Vancouver, BC V6T 1Z3 Canada., Kizhakkedathu JN; The Centre for Blood Research, Department of Pathology and Laboratory Medicine, Vancouver, BC V6T 1Z3 Canada ; Department of Chemistry, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z3 Canada.

Publikováno v: Molecular and cellular therapies [Mol Cell Ther] 2015 Mar 24; Vol. 3, pp. 3. Date of Electronic Publication: 2015 Mar 24 (Print Publication: 2015).